A list of top biotech stocks favored by billionaires includes Exelixis, Inc. Despite challenges in 2024, JPMorgan predicts growth in biotech companies. Investment experts highlight the potential in life sciences and biotech sectors, particularly as Fed rate cuts impact market dynamics.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing